1. Home
  2. MCK vs SNY Comparison

MCK vs SNY Comparison

Compare MCK & SNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo McKesson Corporation

MCK

McKesson Corporation

HOLD

Current Price

$814.96

Market Cap

107.4B

Sector

Health Care

ML Signal

HOLD

Logo Sanofi ADS

SNY

Sanofi ADS

HOLD

Current Price

$48.69

Market Cap

119.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MCK
SNY
Founded
1833
1994
Country
United States
France
Employees
N/A
N/A
Industry
Other Pharmaceuticals
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
107.4B
119.4B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
MCK
SNY
Price
$814.96
$48.69
Analyst Decision
Strong Buy
Buy
Analyst Count
13
5
Target Price
$882.69
$61.50
AVG Volume (30 Days)
848.8K
2.6M
Earning Date
11-05-2025
01-29-2026
Dividend Yield
0.40%
3.28%
EPS Growth
66.19
105.93
EPS
32.12
8.67
Revenue
$387,094,000,000.00
$53,890,648,839.00
Revenue This Year
$14.87
$2.48
Revenue Next Year
$8.32
$6.47
P/E Ratio
$25.34
$5.61
Revenue Growth
17.23
N/A
52 Week Low
$558.13
$44.62
52 Week High
$895.58
$60.12

Technical Indicators

Market Signals
Indicator
MCK
SNY
Relative Strength Index (RSI) 44.67 43.35
Support Level $793.92 $47.80
Resistance Level $818.92 $49.24
Average True Range (ATR) 17.31 0.64
MACD -6.82 -0.16
Stochastic Oscillator 21.63 29.77

Price Performance

Historical Comparison
MCK
SNY

About MCK McKesson Corporation

McKesson Corp is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

Share on Social Networks: